Levalbuterol Solution
Product Images NDC 76204-700

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Levalbuterol (NDC 76204-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 Ct Cards Carton (Rpsc0189 0.31mg 25 Ct Cards Carton)

This text seems to be a mixture of medicine instructions, product labeling, and some random characters and numbers. The medicine is called "Rite Pharmaceuticals" and comes in a 25 x 3 mL Sterile Unit-Dose Vials package, with 0.31 mg for oral inhalation only. There are some unidentifiable characters and non-English phrases included in the text, making it difficult to provide a complete description.*

FDA Label Image

25 Ct Brick Carton (Rpsc0190 0.31mg 25 Ct Brick Carton)

This is a medication for inhalation called "Lavalbutsrol inhalation Solution, USP", with NDC code 7620470025. There is also a string of characters "T R0 000 ) g ST oy TR X" and "Arug voparen 160 1" which are not understandable and may be a result of poor quality.*

FDA Label Image

25 Ct Cards Carton (Rpsc0193 0.63mg 25 Ct Cards Carton)

Levalbuterol Inhalation Solution, USP is a medication for oral inhalation only. The solution comes in 25 x 3 mL sterile unit-dose vials, which comprises 5 pouches of 5 - 3 mL vials each. The NDC code for this medication is 76204-800-55, which specifies that it is Ritedgse Pharmaceuticals' product. The medication has a concentration of 0.63 mg/3mL.*

FDA Label Image

25 Ct Brick Carton (Rpsc0194 0.63mg 25 Ct Brick Carton)

FDA Label Image

25 Ct Cards Carton (Rpsc0197 1.25mg 25 Ct Cards Carton)

This is a label of a pharmaceutical product intended for oral inhalation. It has the NDC code 76204-900-55 and contains 25 x 3 mL Sterile Unit-Dose Vials (5 pouches of 5 - 3 mL vials each) with a dosage strength of 1.25 mg (0.042%). The product is manufactured by RITEDGSE PHARMACEUTICALS. There are additional characters that do not form meaningful words or sentences.*

FDA Label Image

25 Ct Brick Carton (Rpsc0198 1.25 mg 25 Ct Brick Carton)

This is a drug label for levalbuterol inhalation solution, USP with a concentration of 1.25 mg (0.042%) of levalbuterol in each 3mL unit-dose vial. The solution also contains sodium chloride, edetate disodium, and sulfuric acid for pH adjustment. The solution does not contain preservatives, and the foil pouch, once opened, keeps the vials usable for two weeks, while the individual vials remain usable for only one week. It is made by Ritedose Pharmaceuticals LLC and should be used only as directed by a physician. It is stored at USP controlled room temperature (20°-25°C) and protected from light. The pouch encloses "Patient Information Leaflet" that should be dispensed with the drug. *

FDA Label Image

30 Ct Singles Carton (Rpsc0290 0.31mg 30 Ct Singles Carton)

FDA Label Image

30 Ct Singles Carton (Rpsc0291 0.63mg 30 Ct Singles Carton)

This is the description of a medication named Levalbuterol Inhalation Solution, USP. The information provided includes details about the drug such as dosage, concentration, and usage instructions. The medication is available in a 3mL unit-dose vial and contains 0.63mg of levalbuterol per dose. The solution is meant for oral inhalation only and should be stored at room temperature. The medication comes with a patient information leaflet that should be detached from the package insert and dispensed along with the product. The manufacturer is Ritedose Pharmaceuticals, LLC.*

FDA Label Image

30 Ct Singles Carton (Rpsc0292 1.25mg 30 Ct Singles Carton)

Levalbuterol Inhalation Solution is a medication used for oral inhalation only. The solution is contained in a 3mL unit-dose vial, which contains 1.25 mg of levalbuterol, as well as sodium chloride, edetate disodium, and sulfuric acid to adjust the pH of the solution to 4.0. The solution has no preservatives and should be used as directed by a physician, without exceeding recommended dosage. The medication should be protected from light and stored at 20-25°C (68-77°F). The vials should remain in their protective foil pouches until use, after which they should be used within one week. The medication is produced by Ritedose Pharmaceuticals, LLC, and the consult of physicians is recommended before usage. Not-Available.*

FDA Label Image

Chemical Structure (Levalbuterol 01)

FDA Label Image

Figure 1 (Levalbuterol 02)

FDA Label Image

Figure 2 (Levalbuterol 03)

FDA Label Image

Figure 3 (Levalbuterol 04)

FDA Label Image

Figure 4 (Levalbuterol 05)

FDA Label Image

Figure A (Levalbuterol 06)

The text describes a visual element in a unit-dose vial where a shaded area is used to indicate the twist-off tah portion.*

FDA Label Image

Figure B (Levalbuterol 07)

FDA Label Image

Figure C (Levalbuterol 08)

FDA Label Image

Figure D (Levalbuterol 09)

FDA Label Image

Figure E1 (Levalbuterol 10)

FDA Label Image

Figure E2 (Levalbuterol 11)

The text is readable but there is not enough information to generate a useful description. It appears to be a label or title of a product, possibly a face mask called "Reservoir II".*

FDA Label Image

Figure F (Levalbuterol 12)

FDA Label Image

Figure G1 (Levalbuterol 13)

FDA Label Image

Figure G2 (Levalbuterol 14b)

FDA Label Image

Rdp Logo (Rdp Logo)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.